Overview

N-Acetyl Cysteine (NAC) and inositol have emerged as powerful, evidence-supported tools in the treatment of obsessive-compulsive disorder (OCD), offering new hope to patients beyond traditional pharmaceuticals. In this one-hour webinar, functional psychiatrist and bestselling author, Dr. James Greenblatt, will explore the expanding role of N-Acetyl Cysteine (NAC) and inositol in psychiatric treatment—and the surprising relevance of NAC in treating complex conditions like Long COVID.

From their mechanisms of action to practical, evidence-based supplementation protocols, N-Acetyl Cysteine (NAC) and inositol are promising options for patients struggling with symptoms of OCD and anxiety. But the benefits of these nutraceuticals don’t stop there. As clinical research grows, NAC is gaining attention for its broader therapeutic potential—particularly in addressing oxidative stress and neuroinflammation in emerging, multi-systemic disorders like Long COVID.

Join Dr. Greenblatt to learn essential protocols for confidently integrating these compounds into OCD treatment plan and beyond. Whether you’re new to Functional Psychiatry or looking to deepen your clinical toolkit, this webinar offers valuable insights into translational strategies that bridge research and real-world practice.


Instructor

James Greenblatt, MD

Founder, Chief Medical Officer

Dr. James Greenblatt is a globally recognized pioneer in functional and integrative psychiatry with over 30 years of clinical experience. He has dedicated his career to transforming the treatment of mental health disorders through precision-based approaches that integrate laboratory testing, nutritional interventions, and root-cause analysis. Dr. Greenblatt earned his medical degree and completed a psychiatry residency at George Washington University, and pursued a Child and Adolescent Psychiatry fellowship at Johns Hopkins Medical School. A prolific author, Dr. Greenblatt has written eight books, including the bestseller Finally Focused: The Breakthrough Natural Treatment Plan for ADHD. He serves as an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and Dartmouth College’s Geisel School of Medicine. Previously, he served as Chief Medical Officer for Walden Behavioral Care/Monte Nido, a national mental health organization specializing in eating disorders. In 2019, Dr. Greenblatt founded Psychiatry Redefined, a leading platform for continuing education for clinicians in functional and integrative psychiatry, designed to bridge critical knowledge gaps for mental health professionals. His innovative work combines evidence-based research with decades of clinical expertise in functional and integrative psychiatry to promote personalized, precision medicine approaches for sustainable mental health outcomes. in 2024, Dr. Greenblatt founded Mind Refined, a consumer education platform in functional and integrative approaches to mental healthcare. Dr. Greenblatt lectures internationally on nutritional psychiatry and functional medicine’s transformative role in treating mental illnesses.